Abstract
IN a highly interesting session delivered at the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) congress 2023, experts presented and discussed a range of exciting new technologies. Specifically, embolic protection devices, a clot aspiration pump, and a device that scores calcified aortic valves were presented, along with an intelligent conversational transcatheter aortic valve implantation (TAVI) agent. Chaim Lotan, Chief Innovation Officer, Hadassah Medical Centre, Israel, chaired the session, encouraging thought provoking discussion surrounding the application of these technologies within the field of interventional cardiology.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
